Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets.
摘要：
Multiple myeloma is a plasma cell malignancy characterized by complex heterogeneous cytogenetic abnormalities. The bone marrow microenvironment promotes multiple myeloma cell growth and resistance to conventional therapies. Although multiple myeloma remains incurable, novel targeted agents, used alone or in combination, have shown great promise to overcome conventional drug resistance and improve patient outcome. Recent oncogenomic studies have further advanced our understanding of the molecular pathogenesis of multiple myeloma, providing the framework for new prognostic classification and identifying new therapeutic targets.
展开
DOI：
10.1038/nrc2189
被引量：
年份：
2007
Nature
(全网免费下载)
Nature
EBSCO
万方医学
doi.org
查看更多
掌桥科研
Europe PMC
NCBI
The Lancet
ResearchGate
ProQuest
EBSCO
EBSCO
mendeley.com
pubfacts.com
emboj.embopress.org
jpet.aspetjournals.org
go.galegroup.com
ftp.palgrave-journals.com
haematologica.org
onAcademic
science-open.com
moh-it.pure.elsevier.com
mysciencework.com
pubmed.com
d.scholar.cnki.net
theoncologist.alphamedpress.org
nejm.org
bloodjournal.org
mct.aacrjournals.org
scienceopen.com
bvsalud.org
readcube.com
Nature
(全网免费下载)
通过文献互助平台发起求助，成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
引用走势
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
